Exagen Inc.XGNNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank85
Studio
Year-over-Year Change

Year-over-year book value per share growth

Latest
2.02%
↓ 70% vs avg
Percentile
P85
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
6.77%
Historical baseline
PeriodValue
Q4 20252.02%
Q3 2025-20.47%
Q2 2025189.11%
Q1 2025-34.16%
Q4 2024-25.65%
Q3 2024-27.13%
Q2 2024-13.17%
Q1 2024-12.44%
Q4 2023-18.15%
Q3 2023-13.97%
Q2 2023-11.88%
Q1 2023-16.97%
Q4 2022-24.93%
Q3 2022-12.57%
Q2 2022-16.05%
Q1 2022-10.46%
Q4 2021-6.59%
Q3 2021-5.88%
Q2 2021-27.38%
Q1 2021137.07%
Q4 2020-5.98%
Q3 2020-7.09%
Q2 2020-5.65%
Q1 2020-9.46%
Q4 2019-88.57%
Q3 2019445.16%
Q2 2019-75.59%
Q1 201994.02%
Q4 20180.00%
Q3 20180.00%
Q2 20180.00%
Q1 20180.00%
Q4 2015-19.01%
Q3 2015-18.85%
Q2 20158.45%
Q1 2015-20.79%
Q4 2014-5.94%
Q3 2014-63.54%
Q2 2014-402.80%
Q1 2014416.02%